Literature DB >> 10030412

Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum.

M Bouvet1, M Milas, G G Giacco, K R Cleary, N A Janjan, J M Skibber.   

Abstract

BACKGROUND: Local excision of rectal cancer preserves anal continence, bladder function, and normal sexual function. However, local recurrence after excision remains a significant problem. To further define the indications for local excision, we analyzed possible factors predictive of recurrence after local excision of rectal cancer.
METHODS: The charts of all patients undergoing local excision of adenocarcinoma of the rectum between 1985 and 1995 at a single institution were reviewed. Patients with metastatic disease at the time of excision and patients treated preoperatively with chemoradiation therapy were excluded. All available slides were reviewed by a single pathologist, who assessed the depth of invasion; the presence or absence of vascular invasion, lymphatic invasion, perineural invasion, and lymphocytic infiltrate; the mucinous status; and the degree of differentiation. Using the log-rank test and Cox proportional hazards model, univariate and multivariate analyses were performed to identify predictors of recurrence.
RESULTS: Ninety patients underwent local excision, 46 transanally and 44 using a Kraske approach. The breakdown of patients by tumor stage was as follows: Tis, 13%; T1, 41%; T2, 30%; T3, 15%; and Tx, 1%. Sixty-eight percent of patients with T1 tumors were treated with postoperative radiotherapy; all patients with T2 or T3 tumors were treated postoperatively with or without 5-fluorouracil. The median duration of follow-up was 51 months. The median tumor diameter was 2.5 cm (range, 0.4 to 7 cm), and the median distance of the tumor from the anal verge was 4.5 cm (range, 1 to 10 cm). The 4-year actuarial local disease-free survival rate broken down by tumor stage was as follows: Tis, 100%; T1, 95%; T2, 80%; and T3, 73%. The median time to local recurrence was 23 months (range, 7 to 61 months). Multivariate analysis showed that only tumor stage and margin status were predictors of local recurrence.
CONCLUSIONS: Local excision and postoperative radiotherapy result in adequate local control of early stage (Tis and T1) adenocarcinoma of the rectum. Higher rates of recurrence were seen in patients with T2 and T3 tumors, especially in those with positive margins.

Entities:  

Mesh:

Year:  1999        PMID: 10030412     DOI: 10.1007/s10434-999-0026-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Prognostic factors for 5-year survival after local excision of rectal cancer.

Authors:  Dong-Bing Zhao; Yong-Kai Wu; Yong-Fu Shao; Cheng-Feng Wang; Jian-Qiang Cai
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

2.  The Role of Transanal Surgery in the Management of T1 Rectal Cancers.

Authors:  Imran Hassan; Paul E Wise; David A Margolin; James W Fleshman
Journal:  J Gastrointest Surg       Date:  2015-06-06       Impact factor: 3.452

3.  Local excision carcinoma in early stage.

Authors:  Ji-Dong Gao; Yong-Fu Shao; Jian-Jun Bi; Su-Sheng Shi; Jun Liang; Yu-Hua Hu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Combining ultrasonic dissection and the Storz operation rectoscope.

Authors:  M M Lirici; M Di Paola; C Ponzano; C G S Hüscher
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

5.  Long-term results of local excision for rectal cancer.

Authors:  Philip B Paty; Garrett M Nash; Paul Baron; Maureen Zakowski; Bruce D Minsky; David Blumberg; Daniel R Nathanson; Jose G Guillem; Warren E Enker; Alfred M Cohen; W Douglas Wong
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

6.  A population-based comparison of overall and disease-specific survival following local excision or abdominoperineal resection for stage I rectal adenocarcinoma.

Authors:  Michelle Olsheski; David Schwartz; Justin Rineer; Angela Wortham; Sonal Sura; Gainosuke Sugiyama; Marvin Rotman; David Schreiber
Journal:  J Gastrointest Cancer       Date:  2013-09

Review 7.  Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges.

Authors:  Patrick E Young; Craig M Womeldorph; Eric K Johnson; Justin A Maykel; Bjorn Brucher; Alex Stojadinovic; Itzhak Avital; Aviram Nissan; Scott R Steele
Journal:  J Cancer       Date:  2014-03-15       Impact factor: 4.207

8.  Local excision followed by early radical surgery in rectal cancer: long-term outcome.

Authors:  Theodor Junginger; Ursula Goenner; Mirjam Hitzler; Tong T Trinh; Achim Heintz; Daniel Wollschläger
Journal:  World J Surg Oncol       Date:  2019-10-08       Impact factor: 2.754

9.  Completion surgery vs. primary TME for early rectal cancer: a national study.

Authors:  William J Lossius; Tore Stornes; Tor A Myklebust; Birger H Endreseth; Arne Wibe
Journal:  Int J Colorectal Dis       Date:  2021-12-16       Impact factor: 2.571

10.  Prognostic value of microvascular density in dukes a and B (t1-t4, n0, m0) colorectal carcinomas.

Authors:  Rafael Uribarrena A; Javier Ortego; Javier Fuentes; Nuria Raventós; Pilar Parra; Rafael Uribarrena E
Journal:  Gastroenterol Res Pract       Date:  2009-11-04       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.